Spring 2016 Vol. 06 Issue 01
-
From the Editor-in-Chief
Cancer Research: Back to the BasicsMore basic research is needed to understand how various alterations in genes lead to cancers.
by William G. Nelson, MD, PhD
-
Editor's Letter
Shoot for the MoonHow can Vice President Joe Biden's "Moonshot" initiative make true progress against cancer?
by Kevin McLaughlin
-
Your Cancer Guide
Contemplating CAMComplementary and alternative medicine (CAM) can supplement, but not replace, established cancer treatments.
by Hester Hill Schnipper
-
Caregiving With Confidence
When Roles ChangeFollow these tips for keeping your sense of self despite a shift in responsibilities.
by Carly O'Brien
-
Practical Pointers
Do You Have Questions for Your Health Care Team?Make the most of email, text messages, Twitter and patient portals.
by Ide Mills
-
The High-Deductible Gamble
High-deductible health insurance plans can leave cancer patients scrambling to pay the bills for tests and treatments.
by Charlotte Huff
-
The Power of 1
Studies focused on individuals rather than large numbers of people can help some patients while advancing knowledge.
by Stephen Ornes
-
Survivor Profile
Living in the Here and NowA metastatic melanoma survivor is hopeful but realistic as new treatments become available.
by Jenny Song
-
Q&A
Easing Into ActivityCancer exercise specialist and survivor Julie Goodale offers tips for staying active during and after treatment.
by Ronni Gordon
-
Sound Advice
Your Questions, Our AnswersWhen a family member wants to stop treatment, addressing post-treatment anxiety and sadness, and considering a clinical trial.
-
Get Involved
The Gift of a GetawayGive patients and their families a break from cancer.
by Maria Wolf
-
In the Moment- Spring 2016
Colleen Bokor, Dana Stewart, Brittany Avin.
Findings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff
Cancer Today Editors’ Picks: 2024Our favorite Cancer Today stories from 2024, as picked by the editors.